{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:45:36Z","timestamp":1790646336145,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cjca.2019.12.002","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T12:10:50Z","timestamp":1575893450000},"page":"408-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Roy M.","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.12.002_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14797\/mdcj-8-3-8","article-title":"Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management","volume":"8","author":"Estep","year":"2012","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.cjca.2019.12.002_bib2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis over the years 2000-2014: cracking the glass ceiling of early death","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2019.12.002_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.12.002_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.12.002_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.12.002_bib6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic clearance of amyloid by antibodies to serum amyloid P component","volume":"373","author":"Richards","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.12.002_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2019.12.002_bib8","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a noncanonical p38a MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2019.12.002_bib9","doi-asserted-by":"crossref","first-page":"H95","DOI":"10.1152\/ajpheart.00186.2013","article-title":"Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death and early mortality in zebrafish","volume":"305","author":"Mishra","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.12.002_bib11","article-title":"Senile systemic amyloidosis; clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2019.12.002_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mus.20448","article-title":"Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with p.Asp187Tyr mutation in the GSN gene","volume":"33","author":"Chastan","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cjca.2019.12.002_bib13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiological assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.12.002_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/ahe.13.10","article-title":"Comparison of cardiac amyloidosis due to wild-type and V122l transthyretin in older adults referred to an academic medical center","volume":"9","author":"Givens","year":"2013","journal-title":"Aging Health"},{"key":"10.1016\/j.cjca.2019.12.002_bib16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A\u00a0study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.12.002_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.hrthm.2012.02.033","article-title":"Prophylactic pacemaker implantation in familital amyloid polyneuropathy","volume":"9","author":"Algalarrondo","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.12.002_bib18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/01.CIR.64.6.1265","article-title":"Significance of the HV interval in 517 patients with chronic bifascicular block","volume":"64","author":"Dhingra","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.12.002_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","author":"Tendler","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.cjca.2019.12.002_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/ehjci\/jew324","article-title":"Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images\u2014reference values and performance in patients with heart failure and left ventricular hypertrophy","volume":"18","author":"Arenja","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2019.12.002_bib21","first-page":"141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.cjca.2019.12.002_bib22","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.12.002_bib23","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guideline for the management of patients with ventricular arrhythmia and the prevention of sudden death","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.12.002_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1540-8167.2005.00321.x","article-title":"Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart","volume":"17","author":"Micochova","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Krist","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.12.002_bib26","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.12.002_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjh.14747","article-title":"Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis","volume":"182","author":"Rezk","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cjca.2019.12.002_bib30","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(97)00653-X","article-title":"Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis","volume":"80","author":"Chamarthi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.12.002_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00695078","article-title":"The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden","volume":"402","author":"Eriksson","year":"1984","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.cjca.2019.12.002_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1540-8159.1984.tb05599.x","article-title":"Pacemaker treatment in familial amyloidosis with polyneuropathy","volume":"7","author":"Eriksson","year":"1984","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2019.12.002_bib34","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19315077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19315077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:08Z","timestamp":1760107268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19315077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0828282X19315077"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.12.002","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}